Metabolic dysfunction‐associated steatotic liver disease is a risk factor for gallstones: A multicenter cohort study

Documenti analoghi

• MetALD Was a More Notable Independent Risk Factor for Reflux Esophagitis Than MASLD: A Multicenter Cohort Study Using Directed Acyclic Graphs
  di: Hiroshi Tanaka, et al.
  Pubblicazione: (2025)
• Impact of metabolic dysfunction‐associated fatty liver disease on the incidence of Helicobacter pylori‐negative gastric cancer
  di: Tomoyuki Nakane, et al.
  Pubblicazione: (2024)
• Profiles associated with significant hepatic fibrosis consisting of alanine aminotransferase >30 U/L, exercise habits, and metabolic dysfunction‐associated steatotic liver disease
  di: Masahito Nakano, et al.
  Pubblicazione: (2024)
• Association of liver fibrosis progression with non–liver‐related mortality in metabolic dysfunction‐associated steatotic liver disease
  di: Toshifumi Tada, et al.
  Pubblicazione: (2025)
• Association of metabolic dysfunction‐associated fatty liver disease with gallstone development: A longitudinal study
  di: Masahiro Sogabe, et al.
  Pubblicazione: (2024)